Japanese Gastric Cancer Care Transformed by Immunotherapy Shift, 12-Year Data Show
A 12-year Japanese database study of 16,573 patients shows first-line nivolumab plus chemotherapy rapidly displaced cisplatin-based regimens in HER2-negative advanced ...
